Immunization, measles second dose in Georgia
Georgia: Immunization, measles second dose was 81.0% in 2024. ▲ Rising
Immunization, measles second dose in Georgia, 2001–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children by the nationally recommended age.
Analysis
The most recent figure for immunization, measles second dose in Georgia is 81.0%, measured in 2024.
The figure is down 5.8% on the previous year and down 6.9% over ten years.
Over the whole period, immunization, measles second dose in Georgia peaked at 97.0% in 2019 and was at its lowest, 8.0%, in 2001.
Georgia ranks 106th of 178 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 24 years of available data.
Immunization, measles second dose in Georgia, year by year
| Year | % of children by the nationally recommended age | Change |
|---|---|---|
| 2001 | 8.0% | — |
| 2002 | 40.0% | +400.0% |
| 2003 | 57.0% | +42.5% |
| 2004 | 75.0% | +31.6% |
| 2005 | 87.0% | +16.0% |
| 2006 | 88.0% | +1.1% |
| 2007 | 92.0% | +4.5% |
| 2008 | 87.0% | -5.4% |
| 2009 | 71.0% | -18.4% |
| 2010 | 84.0% | +18.3% |
| 2011 | 77.0% | -8.3% |
| 2012 | 79.0% | +2.6% |
| 2013 | 89.0% | +12.7% |
| 2014 | 87.0% | -2.2% |
| 2015 | 91.0% | +4.6% |
| 2016 | 85.0% | -6.6% |
| 2017 | 90.0% | +5.9% |
| 2018 | 96.0% | +6.7% |
| 2019 | 97.0% | +1.0% |
| 2020 | 77.0% | -20.6% |
| 2021 | 81.0% | +5.2% |
| 2022 | 78.0% | -3.7% |
| 2023 | 86.0% | +10.3% |
| 2024 | 81.0% | -5.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 67.2% | 8.0% | 92.0% | 9 |
| 2010s | 87.5% | 77.0% | 97.0% | 10 |
| 2020s | 80.6% | 77.0% | 86.0% | 5 |
Countries ranked near Georgia
- 106 Netherlands 81.0% compare
- 106 San Marino 81.0% compare
- 109 Burundi 80.0% compare
- 109 Libya 80.0% compare
- 109 Monaco 80.0% compare
More health data for Georgia
- Un projection of annual infant deaths, annual growth rate -3.7 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.0382 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,310 deaths per 1,000 people (2090)
- Number of infants who die before age 1 26 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.2207 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0286 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.2812 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is immunization, measles second dose in Georgia?
- Immunization, measles second dose in Georgia was 81.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, measles second dose recorded in Georgia?
- The highest recorded value was 97.0% in 2019.
- What is the lowest immunization, measles second dose recorded in Georgia?
- The lowest recorded value was 8.0% in 2001.
- How does Georgia rank for immunization, measles second dose?
- Georgia ranks 106th out of 178 countries with data for 2024.
- Is immunization, measles second dose rising or falling in Georgia?
- Over the last ten years it is down 6.9%. The long-run trend across the full record is rising.
- Where does this Georgia data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, measles second dose (% of children by the nationally recommended age). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.